CRISPR/Cas9 Knockout Cell Lines and Lysates

Laboratory products

CRISPR/Cas9 Knockout Cell Lines and Lysates

14 Feb, 2019

Published over 7 years ago. See the latest and most current information on Laboratory products.

Amsbio has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.

Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the best negative controls to quickly and confidently prove an antibody’s specificity for a target of interest and ensure reproducibility.

Generated in the most widely used HEK293T, HeLa, and A549 cell lines, Amsbio gene edited homozygous knock-out cell lines work in the cells you know and trust. Consequently, you are no longer limited to highly specialised and altered backgrounds. Amsbio offers only 100% knock-out clonal lines meaning you don't have to work with pools of cells containing only a percentage of knockout cells.

Knock-out cell lysates from Amsbio are made from double knock-out cell lines and provide the perfect negative control for Western Blots to validate the specificity of antibodies or be used in functional assays. Each Amsbio knock-out cell lysate product comes with a cell-line matched wild type control.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
DC’s July fireworks pollution spike exposes limits of annual air quality standards
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Predictive maintenance advances in refineries as retrofit sensors mature
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow